NO20024988D0 - Formulering som har mobiliserende aktivitet - Google Patents

Formulering som har mobiliserende aktivitet

Info

Publication number: NO20024988D0
Authority: NO; Norway
Prior art keywords: formulation; mobilizing activity; haematopoietic; mobilizing; activity
Prior art date: 2000-04-18

Application number

NO20024988A

Other languages

English (en)

Other versions

NO20024988L (no

Inventor

Laura Ferro

Roberto Porta

Massimo Iacobelli

Alessandro Massimo Gianni

Carmelo Carlo Stella

Original Assignee

Gentium Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-18

Filing date

2002-10-16

Publication date

2002-10-16

2002-10-16 Application filed by Gentium Spa filed Critical Gentium Spa

2002-10-16 Publication of NO20024988D0 publication Critical patent/NO20024988D0/no

2002-12-02 Publication of NO20024988L publication Critical patent/NO20024988L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Hematology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

NO20024988A 2000-04-18 2002-10-16 Formulering som har mobiliserende aktivitet NO20024988L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP00830293A EP1147777A1 (en)	2000-04-18	2000-04-18	Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en)	2000-04-18	2001-04-10	Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (2)

Publication Number	Publication Date
NO20024988D0 true NO20024988D0 (no)	2002-10-16
NO20024988L NO20024988L (no)	2002-12-02

Family

ID=8175292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024988A NO20024988L (no)	2000-04-18	2002-10-16	Formulering som har mobiliserende aktivitet

Country Status (31)

Country	Link
US (1)	US20040131588A1 (no)
EP (3)	EP1147777A1 (no)
JP (1)	JP5205668B2 (no)
KR (1)	KR100849491B1 (no)
CN (1)	CN1183962C (no)
AT (2)	ATE310532T1 (no)
AU (2)	AU5832201A (no)
BG (1)	BG107203A (no)
CA (1)	CA2406179C (no)
CY (1)	CY1104971T1 (no)
CZ (1)	CZ20023426A3 (no)
DE (2)	DE60140015D1 (no)
DK (2)	DK1276497T3 (no)
EE (1)	EE200200596A (no)
ES (2)	ES2252227T3 (no)
HR (1)	HRP20020835A2 (no)
HU (1)	HUP0300560A3 (no)
IL (1)	IL152328A (no)
IS (1)	IS2171B (no)
MX (1)	MXPA02010346A (no)
NO (1)	NO20024988L (no)
NZ (1)	NZ522016A (no)
PL (1)	PL358100A1 (no)
PT (1)	PT1621207E (no)
RO (1)	RO121006B1 (no)
RU (1)	RU2248216C2 (no)
SI (1)	SI21079B (no)
SK (1)	SK14892002A3 (no)
UA (1)	UA73566C2 (no)
WO (1)	WO2001078761A2 (no)
ZA (1)	ZA200208413B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8771663B2 (en)	2000-04-18	2014-07-08	Gentium Spa	Formulation having mobilising activity
PL1660115T3 (pl) *	2003-07-29	2011-11-30	Dompe Spa	Farmaceutyczna kombinacja G-CSF i PLGF użyteczna wobec komórek macierzystych krwi
JP2007535479A (ja)	2003-08-13	2007-12-06	チルドレンズホスピタルメディカルセンター	ＧＴＰａｓｅを調節するためのキメラペプチド
US7417026B2 (en)	2003-08-13	2008-08-26	Children's Hospital Medical Center	Mobilization of hematopoietic cells
EP2103689A1 (en) *	2008-03-19	2009-09-23	Gentium S.p.A.	Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) *	2008-07-17	2009-12-27	Владислав Николаевич Ласкавый	Средство для активации стволовых клеток
EP2637672B1 (en)	2010-11-12	2018-08-22	Gentium S.r.l.	Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
CA2874960C (en)	2012-06-22	2021-05-18	Gentium S.P.A.	Euglobulin-based method for determining the biological activity of defibrotide
EP3026122A1 (en)	2014-11-27	2016-06-01	Gentium S.p.A.	Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) *	2016-11-14	2017-04-19	北京国泰通源技术有限公司	智能控水短节
RU2758487C2 (ru) *	2018-01-12	2021-10-28	Селлмиг Биолабс Инк.	Способы получения цитокапсул и цитокапсулярных трубок
CN114730031B (zh)	2019-11-13	2024-04-12	富士胶片株式会社	装饰膜、成型物及电子器件

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3899481A (en)	1970-11-03	1975-08-12	Crinos Industria Farmaco	Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
DE2154279A1 (de) *	1970-11-03	1972-05-25	Crinos Industria Farmaco	Medikamente für das fibrinolytische System
IT1043823B (it) *	1970-11-03	1980-02-29	Prephar	Procedimento per l estrazione di acidi nucleici da organi animali
IT1206341B (it)	1984-02-16	1989-04-14	Crinos Industria Farmaco	Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en)	1985-05-28	1987-09-15	Ajax Magnethermic Corporation	Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) *	1986-04-17	1993-06-29	Crinos Industria Farmacobiologica S.P.A.	Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it)	1986-04-17	1988-02-16	Crinos Industria Farmaco	Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) *	1987-10-23	1990-09-19	Crinos Industria Farmaco	Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) *	1988-08-24	1999-06-21	中外製薬株式会社	抗血栓剤
IT1231509B (it) *	1989-09-07	1991-12-07	Crinos Industria Farmaco	Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) *	1991-06-07	1993-04-06	Immunex Corporation	Method for improving autologous transplantation
US5977083A (en) *	1991-08-21	1999-11-02	Burcoglu; Arsinur	Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) *	1992-01-28	2000-03-15	松下電器産業株式会社	電動調理機
RU2136667C1 (ru) *	1995-04-18	1999-09-10	Научно-исследовательский институт фармакологии РАМН	Производные 2-меркаптобензимидазола, обладающие противоишемической, антиаритмической и противофибрилляторной активностью
JPH08127539A (ja) *	1994-10-31	1996-05-21	Ajinomoto Co Inc	ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
EP0801076A4 (en) *	1994-11-30	1999-12-15	Chugai Pharmaceutical Co Ltd	THROMBOCYTOTIC FACTOR
CA2260014A1 (en) *	1996-07-10	1998-01-15	Meiji Milk Products Co., Ltd.	Novel use of mk family as hematopoietic factor
WO1999026639A1 (en) *	1997-11-26	1999-06-03	Allegheny University Of The Health Sciences	Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) *	1999-01-07	2003-06-03	Heska Corporation	Feline immunoglobulin E molecules and compositions there of

2000
- 2000-04-18 EP EP00830293A patent/EP1147777A1/en not_active Withdrawn
2001
- 2001-04-10 DE DE60140015T patent/DE60140015D1/de not_active Expired - Lifetime
- 2001-04-10 AT AT01931582T patent/ATE310532T1/de active
- 2001-04-10 EP EP01931582A patent/EP1276497B1/en not_active Expired - Lifetime
- 2001-04-10 AU AU5832201A patent/AU5832201A/xx active Pending
- 2001-04-10 CA CA2406179A patent/CA2406179C/en not_active Expired - Fee Related
- 2001-04-10 DK DK01931582T patent/DK1276497T3/da active
- 2001-04-10 HU HU0300560A patent/HUP0300560A3/hu unknown
- 2001-04-10 CN CNB018082025A patent/CN1183962C/zh not_active Expired - Fee Related
- 2001-04-10 EE EEP200200596A patent/EE200200596A/xx unknown
- 2001-04-10 HR HR20020835A patent/HRP20020835A2/xx not_active Application Discontinuation
- 2001-04-10 KR KR1020027013967A patent/KR100849491B1/ko not_active Expired - Fee Related
- 2001-04-10 NZ NZ522016A patent/NZ522016A/en unknown
- 2001-04-10 MX MXPA02010346A patent/MXPA02010346A/es active IP Right Grant
- 2001-04-10 DK DK05108424.2T patent/DK1621207T3/da active
- 2001-04-10 SI SI200120022A patent/SI21079B/sl not_active IP Right Cessation
- 2001-04-10 AU AU2001258322A patent/AU2001258322B2/en not_active Ceased
- 2001-04-10 CZ CZ20023426A patent/CZ20023426A3/cs unknown
- 2001-04-10 AT AT05108424T patent/ATE443524T1/de active
- 2001-04-10 US US10/432,741 patent/US20040131588A1/en not_active Abandoned
- 2001-04-10 DE DE60115222T patent/DE60115222T2/de not_active Expired - Lifetime
- 2001-04-10 ES ES01931582T patent/ES2252227T3/es not_active Expired - Lifetime
- 2001-04-10 SK SK1489-2002A patent/SK14892002A3/sk unknown
- 2001-04-10 JP JP2001576061A patent/JP5205668B2/ja not_active Expired - Fee Related
- 2001-04-10 RO ROA200201305A patent/RO121006B1/ro unknown
- 2001-04-10 IL IL152328A patent/IL152328A/en active IP Right Grant
- 2001-04-10 PL PL01358100A patent/PL358100A1/xx not_active Application Discontinuation
- 2001-04-10 ES ES05108424T patent/ES2335776T3/es not_active Expired - Lifetime
- 2001-04-10 WO PCT/EP2001/004105 patent/WO2001078761A2/en not_active Ceased
- 2001-04-10 PT PT05108424T patent/PT1621207E/pt unknown
- 2001-04-10 EP EP05108424A patent/EP1621207B1/en not_active Expired - Lifetime
- 2001-04-10 RU RU2002130719/15A patent/RU2248216C2/ru not_active IP Right Cessation
- 2001-10-04 UA UA2002119177A patent/UA73566C2/uk unknown
2002
- 2002-10-14 IS IS6581A patent/IS2171B/is unknown
- 2002-10-16 NO NO20024988A patent/NO20024988L/no not_active Application Discontinuation
- 2002-10-17 ZA ZA200208413A patent/ZA200208413B/en unknown
- 2002-10-17 BG BG107203A patent/BG107203A/bg unknown
2006
- 2006-02-08 CY CY20061100179T patent/CY1104971T1/el unknown

Also Published As

Publication number	Publication date
IL152328A (en)	2009-12-24
ES2335776T3 (es)	2010-04-05
US20040131588A1 (en)	2004-07-08
SI21079A (sl)	2003-06-30
JP5205668B2 (ja)	2013-06-05
DK1621207T3 (da)	2010-02-01
WO2001078761A2 (en)	2001-10-25
KR20030010603A (ko)	2003-02-05
RO121006B1 (ro)	2006-11-30
RU2248216C2 (ru)	2005-03-20
PL358100A1 (en)	2004-08-09
DK1276497T3 (da)	2006-03-27
SK14892002A3 (sk)	2003-06-03
IL152328A0 (en)	2003-05-29
PT1621207E (pt)	2009-12-28
NZ522016A (en)	2004-10-29
CN1434719A (zh)	2003-08-06
CA2406179A1 (en)	2001-10-25
ATE443524T1 (de)	2009-10-15
EP1276497A2 (en)	2003-01-22
HRP20020835A2 (en)	2005-10-31
ZA200208413B (en)	2003-10-17
DE60115222T2 (de)	2006-08-10
ATE310532T1 (de)	2005-12-15
EP1621207A2 (en)	2006-02-01
CZ20023426A3 (cs)	2003-05-14
DE60115222D1 (de)	2005-12-29
EP1276497B1 (en)	2005-11-23
EP1147777A1 (en)	2001-10-24
CA2406179C (en)	2012-03-27
EP1621207B1 (en)	2009-09-23
IS2171B (is)	2006-11-15
DE60140015D1 (de)	2009-11-05
AU2001258322B2 (en)	2006-03-16
CN1183962C (zh)	2005-01-12
EP1621207A3 (en)	2006-11-22
CY1104971T1 (el)	2010-03-03
MXPA02010346A (es)	2004-09-06
JP2004500437A (ja)	2004-01-08
HUP0300560A2 (hu)	2003-06-28
SI21079B (sl)	2006-08-31
UA73566C2 (en)	2005-08-15
KR100849491B1 (ko)	2008-07-31
RU2002130719A (ru)	2004-03-27
NO20024988L (no)	2002-12-02
WO2001078761A3 (en)	2002-01-24
IS6581A (is)	2002-10-14
HUP0300560A3 (en)	2005-07-28
BG107203A (bg)	2003-05-30
ES2252227T3 (es)	2006-05-16
AU5832201A (en)	2001-10-30
EE200200596A (et)	2004-04-15

Publication	Publication Date	Title
NO20024988D0 (no)	2002-10-16	Formulering som har mobiliserende aktivitet
AU2001269688A1 (en)	2002-01-14	Combination containing an antifolate and methylmalonic acid lowering agent
DE60143477D1 (de)	2010-12-30	Verminderung der nebenwirkungen bei der oxybutynin-therapie
NO20061095L (no)	1995-07-13	Vertscelle som fremstiller chimerisk anti-CD2o-antistoff samt anvendelse derav ved fremstilling av medikamenter til behandling av lidelser som involverer B-celler
MXPA02003809A (es)	2004-03-10	Articulo absorbente desechable con estructura de contencion.
DE69932248D1 (de)	2006-08-17	Entzündungshemmende ascorbinsäurederivate
DK261490D0 (da)	1990-10-31	New pharmaceutical compound
NO20034504D0 (no)	2003-10-08	Erytropoietin forbedrer in vivo kjemoterapiindusert toksisitet
IT1264530B (it)	1996-10-02	Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
WO2001089536A3 (en)	2002-08-01	Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
AU2002332488A8 (en)	2004-02-25	R-bambuterol, its preparation and therapeutic uses
TR200302008T4 (tr)	2004-01-21	Dış retina bozukluklarının tedavisine yönelik bir ilaç üretiminde beta-adrenoseptör antagonistlerin kullanımı.
YU79802A (sh)	2005-11-28	Formulacija sa aktivnošću mobilizacije
SE0000303D0 (sv)	2000-01-31	Novel compounds
SE0003092D0 (sv)	2000-09-01	New Use
ES2160093A1 (es)	2001-10-16	Derivados del acido p-hidroxifenil propionico como agentes antiproliferativos.
PT1093380E (pt)	2003-01-31	Componente b como agente angiogenico em combinacao com factores de crescimento humano
DK1086695T3 (da)	2005-04-25	Antivirale præparater omfattende yohimbin som aktivt princip
MX9302644A (es)	1994-06-30	Nuevos enantiomeros derivados de (s)-2-amino-2-(3-4-diclorobencil)-1-propanol-
ES2165788B1 (es)	2003-04-16	Empleo de la levadura de cerveza en la elaboracion de un medicamento para el tratamiento del sindrome x fragil.
IT7827270A0 (it)	1978-09-01	Corpo di distribuzione ad ugello coassiale, in particolare per siringhe dentali combinate.

Legal Events

Date	Code	Title	Description
2009-11-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application